0001225208-18-011613.txt : 20180711
0001225208-18-011613.hdr.sgml : 20180711
20180711193831
ACCESSION NUMBER: 0001225208-18-011613
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180711
DATE AS OF CHANGE: 20180711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wengel Kathryn E
CENTRAL INDEX KEY: 0001745955
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 18949440
MAIL ADDRESS:
STREET 1: JOHNSON & JOHNSON
STREET 2: ONE JOHNSON & JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
3
1
doc3.xml
X0206
3
2018-07-02
0
0000200406
JOHNSON & JOHNSON
JNJ
0001745955
Wengel Kathryn E
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
EVP, Chief GSC Officer
Common Stock
34290.0363
D
Common Stock
17.0000
I
By 401k
Common Stock
281.0000
I
By ESOP
Employee Stock Options (Right to Buy)
62.2000
2014-01-11
2021-01-08
Common Stock
8238.0000
D
Employee Stock Options (Right to Buy)
62.6200
2013-02-09
2020-02-07
Common Stock
2017.0000
D
Employee Stock Options (Right to Buy)
65.3700
2015-01-18
2022-01-17
Common Stock
7877.0000
D
Employee Stock Options (Right to Buy)
72.5400
2016-01-17
2023-01-13
Common Stock
56410.0000
D
Employee Stock Options (Right to Buy)
90.4400
2017-02-11
2024-02-09
Common Stock
35638.0000
D
Employee Stock Options (Right to Buy)
100.0600
2018-02-10
2025-02-09
Common Stock
32762.0000
D
Employee Stock Options (Right to Buy)
101.8700
2019-02-09
2026-02-08
Common Stock
38945.0000
D
Employee Stock Options (Right to Buy)
115.6700
2020-02-13
2027-02-13
Common Stock
42965.0000
D
Employee Stock Options (Right to Buy)
129.5100
2021-02-12
2028-02-11
Common Stock
33044.0000
D
Restricted Share Units
2019-02-08
Common Stock
5882.0000
D
Restricted Share Units
2021-02-12
Common Stock
1658.0000
D
Restricted Share Units
2020-02-13
Common Stock
7592.0000
D
Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2018).
Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/30/2018).
Vested and exercisable one day after the third anniversary of the date of the grant.
Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.
wengelpoa.txt
Linda E. King, as attorney-in-fact for Kathryn E. Wengel
2018-07-11
EX-24
2
wengelpoa.txt
POWER OF ATTORNEY
Executive Officers
Know all persons by these presents, that the undersigned hereby
constitutes and appoints each of Thomas J. Spellman III, Tina French,
Linda E. King, Maria Frucci and Michelle Ryan, signing singly, as the
undersigned's true and lawful attorneys-in-fact to:
(1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an executive officer of Johnson & Johnson
(the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of
the Securities Exchange Act of 1934, as amended, and the rules
thereunder (the "Exchange Act") and Form 144 in accordance with Rule
144 of the Securities Act of 1933, as amended (the "Securities Act");
(2) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Form 3, 4, 5 and 144 and timely file such form with
the United States Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-fact, may
be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney-in
-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's
substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys
-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the
Exchange Act or Rule 144 of the Securities Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file reports pursuant to Section
16 of the Exchange Act with respect to the undersigned's holdings of
and transactions in securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of the date set forth below.
/s/ Kathryn E. Wengel
Name: Kathryn E. Wengel
Date: July 3, 2018